Injection Technique in Subacromial Impingement Syndrome (SAIS)

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Status

Completed

Conditions

Subacromial Impingement Syndrome

Treatments

Other: subacromial corticosteroid injections

Study type

Observational

Funder types

Other

Identifiers

NCT05266391

PMRTURKEY

Details and patient eligibility

About

Since pain is usually accompanied by a substantial effect on daily life that results in the extensive use of healthcare resources. In subacromial impingement syndrome, shoulder pain affects the quality of life negatively by affecting upper extremity functions and interrupting night sleep. It is very important to control the pain in order to reduce the loss to the labor force and prevent the pain from becoming chronic. Various physical treatment methods such as ultrasound, hot pack, transcutaneous electrical nerve stimulation, etc., and injections or medical agents are recommended. This study aimed to compare the effects of ultrasound (US)-guided in comparison to landmark guided subacromial corticosteroids injection on shoulder range of motion (ROM), pain, and functional status in patients with subacromial impingement syndrome (SAIS).

Full description

Patients were assigned to two groups: Group-1 included patients who received US-guided subacromial corticosteroid injections; Group-2 included patients who underwent blind subacromial corticosteroid injections. The primary Outcome Measure was a Visual analog scale. Secondary Outcome Measures were Shoulder joint range of motion (ROM), Shoulder Pain and Disability Index (SPADI), The Shortened Disabilities of the Arm, Shoulder and Hand Questionnaire (Quick DASH).

Enrollment

40 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Shoulder posterolateral pain that increased with shoulder abduction,
Restriction of the shoulder passive and active range of motion (ROM),
Patients with positive Neer and Hawkins impingement test,
Patients with SAIS whose diagnosis was confirmed by magnetic resonance imaging (MRI), and
Patients with SAIS whose application of corticosteroid in their injections were the same in terms of type and dose (1 ml betamethasone dipropionate + betamethasone sodium phosphate).

Exclusion criteria

Patients who received corticosteroid, local anesthetic, hyaluronic acid, and platelet-rich plasma injections in the shoulder in the last one year,
patients who had previous history of surgery or fracture in their thorax, neck, upper extremity or shoulder joint,
patients with a rheumatological, cognitive or psychiatric, central or peripheral neurological disease (stroke, spinal cord injury, brachial plexus injury, etc.),
patients whose MRI presented a partial or complete rotator cuff tear, calcific tendinitis or labral tear.